Manual vacuum aspiration or MVA is a procedure used to remove the womb's pregnancy remnants. It employs gentle suction while you are awake and under a local anesthetic. This can be used instead of a general anesthetic in a theatre. This is used to treat miscarriage victims and situations when tissue remains after a miscarriage.
Aspiration kits are a reliable and appropriate method for managing the evacuation of the uterine cavity between 5 and 12 weeks of pregnancy or for concurrent endometrial curettage. MVA can be carried out under local anesthetic and may be carried out in an Outpatient department setting, which not only frees up valuable operating theatre space but also saves money. A sterile Double aspiration valve device is used for quick uterine aspiration or evacuation during gynaecological procedures.
Before the surgery, a vacuum of up to 610-660mm Hg pressure can be created using sterile, single-use equipment with a unique locking double valve system. The suction is precisely and instantly released upon depressing the twin valve finger-tip control. This lessens the likelihood of "slow" progressive suction pressure, which can cause uterine bleeding when the vacuum is insufficient.
A vaginal pessary (misoprostol) will be administered an hour before the surgery to soften the cervix. Before the procedure, we will also give you a painkiller (diclofenac suppository). The rear passage is where you administer this to yourself. We'll then take you to the operating room. Per our request, your legs should be in stirrups while lying on the couch.
A tube-shaped instrument called a speculum would next be inserted into your vagina. During the process, this will remain in place. Your cervix will get an injection of local anesthetic (numbing medication). The cervix is then gradually dilated or extended. The leftover pregnancy tissue is extracted from the womb using a tiny suction tube.
The adoption of manual vacuum aspiration (MVA) as a safe and practical alternative method of uterine evacuation is one of the most crucial strategies for avoiding complications of unsafe abortions globally. This technology benefits national health systems in numerous ways, including decreased service delivery costs, more comprehensive access to post-abortion care at lower-level medical facilities, and fewer severe medical consequences.
However, the equipment used for MVA differs in quality, cost, and local availability. The procedures and standards developed for all of these tests may be crucial future guides for evaluating products that were not evaluated (such as new products and those that were not accessible at the time of the evaluation), in addition to offering helpful information about how the instruments evaluated withstand real-life conditions.